Stock Taper
BNR
BURNING ROCK BIOTECH LIMITED
NASDAQ
$10.19
▲ UP 1.90% (0.19)

KEY STATISTICS

Market Cap$10.77 M
52w High$41.72
52w Low$6.79
Dividend Yield
Frequency
P/E-12.43
Volume28.91K
Shares Out.1.06M

COMPANY

LEADERSHIP

Yusheng Han
CHIEF EXECUTIVE
Yusheng Han

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 12, 2020
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
667

UPCOMING EARNINGS

DateSep 2, 2026
DayWednesday
Rev. Est.$19.21M
SEP
2
WED

SPLIT RECORD

DATETYPERATIO
2024-05-15Reverse1:10
2014-08-01Reverse1:3

PRICE

$10.19 ▲ UP 1.90% (+$0.19)
OVERLAYS
$9.50$9.75$10.00$10.259:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM10.19

About Burning Rock Biotech Limited

https://www.brbiotech.com ↗

Burning Rock Biotech Limited develops and offers NGS-based cancer therapy tests in China, covering various cancers with collaborations and licensed products for personalized diagnosis and treatment.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT BURNING ROCK BIOTECH LIMITED IS KNOWN FOR

OncoGuide™ OncoScreen™ Plus CDx System
OncoGuide™ OncoScreen™ Plus CDx System

Burning Rock's companion diagnostic system uses next-generation sequencing to detect gene alterations in breast cancer, identifying patients for AstraZeneca's capivasertib and fulvestrant, with recent Japan approval advancing its global strategy.

Revenue by Products

IconPRODUCTQ2-2022Q4-2022
Service$185.58M $205.97M
Product$80.79M $90.9M

Revenue by Geography

MapREGIONFY2022FY2023FY2024
CHINA$553.3M $534.93M $510.24M
UNITED STATES$2.51M $5.58M

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book5
Overall Score2

INSIDER TRADES

DIRECTOR
Han Yusheng
Purchase · 111.1K shares
2026-06-16
DIRECTOR
Han Yusheng
Purchase · 210.0K shares
2026-06-12
DIRECTOR
Han Yusheng
Purchase · 104.7K shares
2026-06-22
DIRECTOR
Han Yusheng
Purchase · 24.8K shares
2026-06-11

SECTORS PEERS

PEERPRICE
AYTU$2.25COMPARE
PMN$13.79COMPARE
ADVB$9.70COMPARE
CODX$1.21COMPARE
AEMD$2.49COMPARE
PRPH$0.02COMPARE
NVNO$10.75COMPARE